Abstract
Inflammatory bowel diseases (IBD), subdivided into Crohn’s disease (CD) and ulcerative colitis (UC), are chronic diseases that are characterized by relapsing and remitting periods of inflammation in the gastrointestinal tract. In recent years, the amount of research surrounding digital health (DH) and artificial intelligence (AI) has increased. The purpose of this scoping review is to explore this growing field of research to summarize the role of DH and AI in the diagnosis, treatment, monitoring and prognosis of IBD. A review of 21 articles revealed the impact of both AI algorithms and DH technologies; AI algorithms can improve diagnostic accuracy, assess disease activity, and predict treatment response based on data modalities such as endoscopic imaging and genetic data. In terms of DH, patients utilizing DH platforms experienced improvements in quality of life, disease literacy, treatment adherence, and medication management. In addition, DH methods can reduce the need for in-person appointments, decreasing the use of healthcare resources without compromising the standard of care. These articles demonstrate preliminary evidence of the potential of DH and AI for improving the management of IBD. However, the majority of these studies were performed in a regulated clinical environment. Therefore, further validation of these results in a real-world environment is required to assess the efficacy of these methods in the general IBD population.
Highlights
By recognizing key themes and current gaps in the areas of digital health (DH) and artificial intelligence (AI) as they pertain to the care of Inflammatory bowel disease (IBD) patients, we can build on current research and direct new research questions
What is the role of digital health and artificial intelligence in the diagnosis, treatment, monitoring, and prognosis of inflammatory bowel disease?
We explored the impact of DH and AI on IBD through four main areas of the course of disease: diagnosis, treatment, monitoring, and prognosis
Summary
Inflammatory bowel disease (IBD), which encompasses ulcerative colitis (UC) and. Common symptoms of IBD include abdominal pain, diarrhea, rectal bleeding, fatigue, and extraintestinal manifestations of the disease [2]. UC is characterized by episodes of inflammation limited to the mucosal layer of the colon. Assessments of severity can vary based on the specific index or score used, such as the Montreal classification of IBD and the UC Colonoscopic Index of Severity [3,4,5]. Practice guidelines stratify patients into either a low- or high-risk category by assessing inflammatory status in order to estimate the risk of long-term sequelae such as colectomy [3]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
